These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29777797)

  • 1. Polypharmacy, defined as taking five or more drugs, is inadequate in the cardiovascular setting.
    Abolhassani N; Marques-Vidal P
    J Clin Epidemiol; 2018 Sep; 101():1-4. PubMed ID: 29777797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-Year Trend in Polypharmacy in the Lausanne Population.
    Abolhassani N; Vollenweider P; Waeber G; Marques-Vidal P
    J Patient Saf; 2021 Jun; 17(4):e269-e273. PubMed ID: 32168266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of change in polypharmacy status in Switzerland: the population-based CoLaus study.
    Abolhassani N; Castioni J; Marques-Vidal P; Vollenweider P; Waeber G
    Eur J Clin Pharmacol; 2017 Sep; 73(9):1187-1194. PubMed ID: 28634642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The challenge of polypharmacy in cardiovascular medicine.
    Volpe M; Chin D; Paneni F
    Fundam Clin Pharmacol; 2010 Feb; 24(1):9-17. PubMed ID: 19817871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study.
    Jyrkkä J; Vartiainen L; Hartikainen S; Sulkava R; Enlund H
    Eur J Clin Pharmacol; 2006 Feb; 62(2):151-8. PubMed ID: 16408226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-based pattern of medication use and prevalence of polypharmacy among patients with cardiovascular diseases: results of the Pars cohort study from Iran.
    Mohsenzadeh P; Ardekani A; Poustchi H; Mohammadi Z; Abdipour Mehrian SR; Bazrafshan Drissi H; Rahimian Z; Taherifard E; Nabavizadeh A; Kamalipour A; Mesgarpour B; Malekzadeh F; Molavi Vardanjani H
    BMC Cardiovasc Disord; 2022 Oct; 22(1):435. PubMed ID: 36203125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future.
    Marković-Peković V; Škrbić R; Petrović A; Vlahović-Palčevski V; Mrak J; Bennie M; Fadare J; Kwon HY; Schiffers K; Truter I; Godman B
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):609-618. PubMed ID: 26671843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study.
    Castioni J; Marques-Vidal P; Abolhassani N; Vollenweider P; Waeber G
    BMC Health Serv Res; 2017 Dec; 17(1):840. PubMed ID: 29268737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypharmacy in Cardiovascular Medicine: Problems and Promises!
    Abolbashari M; Macaulay TE; Whayne TF; Mukherjee D; Saha S
    Cardiovasc Hematol Agents Med Chem; 2017 Nov; 15(1):31-39. PubMed ID: 28552061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The consumption of two or more fall risk-increasing drugs rather than polypharmacy is associated with falls.
    Zia A; Kamaruzzaman SB; Tan MP
    Geriatr Gerontol Int; 2017 Mar; 17(3):463-470. PubMed ID: 26822931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with appropriate knowledge of the indications for prescribed drugs among community-dwelling older patients with polypharmacy.
    Bosch-Lenders D; Maessen DW; Stoffers HE; Knottnerus JA; Winkens B; van den Akker M
    Age Ageing; 2016 May; 45(3):402-8. PubMed ID: 27013501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication Underuse in Aging Outpatients with Cardiovascular Disease: Prevalence, Determinants, and Outcomes in a Prospective Cohort Study.
    Meid AD; Quinzler R; Freigofas J; Saum KU; Schöttker B; Holleczek B; Heider D; König HH; Brenner H; Haefeli WE
    PLoS One; 2015; 10(8):e0136339. PubMed ID: 26288222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication and dry mouth: findings from a cohort study of older people.
    Thomson WM; Chalmers JM; Spencer AJ; Slade GD
    J Public Health Dent; 2000; 60(1):12-20. PubMed ID: 10734611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Polypharmacy in Nursing Homes Affect Long-Term Mortality?
    Schlesinger A; Weiss A; Nenaydenko O; Adunsky A; Beloosesky Y
    J Am Geriatr Soc; 2016 Jul; 64(7):1432-8. PubMed ID: 27304579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial.
    Proietti M; Raparelli V; Olshansky B; Lip GY
    Clin Res Cardiol; 2016 May; 105(5):412-20. PubMed ID: 26525391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort.
    Klarin I; Fastbom J; Wimo A
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):669-78. PubMed ID: 14762983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increasing burden and complexity of multi-morbidity and polypharmacy in geriatric HIV patients: a cross sectional study of people aged 65 - 74 years and more than 75 years.
    Guaraldi G; Malagoli A; Calcagno A; Mussi C; Celesia BM; Carli F; Piconi S; De Socio GV; Cattelan AM; Orofino G; Riva A; Focà E; Nozza S; Di Perri G
    BMC Geriatr; 2018 Apr; 18(1):99. PubMed ID: 29678160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy is associated with frailty in Japanese community-dwelling older adults.
    Yuki A; Otsuka R; Tange C; Nishita Y; Tomida M; Ando F; Shimokata H
    Geriatr Gerontol Int; 2018 Oct; 18(10):1497-1500. PubMed ID: 30168240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK.
    Becerra V; Gracia A; Desai K; Abogunrin S; Brand S; Chapman R; García Alonso F; Fuster V; Sanz G
    BMJ Open; 2015 May; 5(5):e007111. PubMed ID: 25991449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription refill management and its effect on adherence: comment on "the implications of therapeutic complexity on adherence to cardiovascular medications".
    Salanitro AH; Kripalani S
    Arch Intern Med; 2011 May; 171(9):822-3. PubMed ID: 21220643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.